Neoadjuvant Immunotherapy in Brain Metastases
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Brain Metastases, Adult
Interventions: DRUG: Nivolumab|DRUG: Ipilimumab
Sponsor: Sarah Sammons, MD
Collaborators: Bristol-Myers Squibb|Duke University